In addition SLC13A3 (NaDC3) has been suggested to participate in the pathogenesis of the two inborn metabolic diseases glutaric aciduria type 1 (GA1) and Canavan disease (CD). This evidence concerns the gene SLC13A3 and glutaryl-CoA dehydrogenase deficiency.